Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

OnDecember11,2020, theUSFoodandDrugAdministration(FDA) issued an Emergency Use Authorization (EUA) for the Pfizer- BioNTech coronavirus disease 2019 (COVID-19) vaccine, administered as 2 doses separated by
21 days. Shortly after, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for its use.

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
Size: 107 KB